After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Apellis Pharmaceuticals Inc is $3.62B. A total of 1.91 million shares were traded on the day, compared to an average of 2.31M shares.
In the most recent transaction, Chopas James George sold 548 shares of APLS for 28.08 per share on Sep 02 ’25. After the transaction, the VP/Chief Accounting Officer now owns 53,657 company shares. In a previous transaction on Sep 02 ’25, Chopas James George bought 548 shares at 28.08 per share.
Among the insiders who sold shares, Francois Cedric disposed of 175,037 shares on Aug 27 ’25 at a per-share price of $28.19. This resulted in the Chief Executive Officer holding 357,909 shares of APLS after the transaction. In another insider transaction, Francois Cedric sold 49,963 shares at $28.39 per share on Aug 28 ’25. Company shares held by the Chief Executive Officer now total 307,946.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, APLS has a high of $41.94 and a low of $16.10.
As of this writing, APLS has an earnings estimate of $0.91 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $2.03 per share and a lower estimate of -$0.61. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $1.24, while its Total Shareholder’s Equity was $198.66M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.04.
